Blueprint Investment Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,751
Closed -$585K 223
2023
Q1
$585K Buy
10,751
+5,670
+112% +$276K 0.13% 98
2022
Q4
$246K Buy
+5,081
New +$223K 0.05% 185
2022
Q3
Sell
-5,878
Closed -$294K 183
2022
Q2
$294K Sell
5,878
-1,471
-20% -$78.1K 0.08% 112
2022
Q1
$377K Buy
+7,349
New +$379K 0.1% 120

Other funds holding SNY

Blueprint Investment Partners's SNY Position: Q2 2023 in Review

Blueprint Investment Partners sold out of Sanofi (SNY) in Q2 2023, closing a stake of 10,751 shares — an estimated $585K sold.

Blueprint Investment Partners first reported a position in SNY in Q1 2022 and held it in 4 quarters. The position peaked at $585K in Q1 2023. 672 funds tracked by Wall St. Rank hold SNY as of Q2 2023.

  • Blueprint Investment Partners reported no remaining Sanofi position as of Q2 2023 after selling out during the quarter.
  • Blueprint Investment Partners sold 10,751 Sanofi shares in Q2 2023, an estimated $585K.
  • Blueprint Investment Partners first reported a position in Sanofi in Q1 2022 and held it in 4 quarters.
  • Blueprint Investment Partners's Sanofi position peaked at $585K in Q1 2023.
  • 672 funds tracked by Wall St. Rank held Sanofi as of Q2 2023.

Based on Blueprint Investment Partners's 13F filing for Q2 2023, filed 15 Aug 2023.